HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kyong-Ah Yoon Selected Research

Neoplasm Metastasis (Metastasis)

1/2023Case report: Adjuvant therapy with toceranib for an incompletely resected renal cell carcinoma with suspected pulmonary metastasis in a dog.
1/2022Case report: Toceranib as adjuvant chemotherapy in a dog with incompletely resected combined hepatocellular-cholangiocarcinoma.
1/2021A fusion of CD63-BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kyong-Ah Yoon Research Topics

Disease

21Neoplasms (Cancer)
02/2024 - 01/2004
6Lung Neoplasms (Lung Cancer)
04/2016 - 11/2006
5Pancreatic Neoplasms (Pancreatic Cancer)
02/2024 - 05/2002
5Adenocarcinoma of Lung
01/2021 - 04/2008
4Breast Neoplasms (Breast Cancer)
05/2019 - 06/2009
3Neoplasm Metastasis (Metastasis)
01/2023 - 01/2021
3Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2019 - 04/2016
3Stomach Neoplasms (Stomach Cancer)
01/2018 - 06/2008
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2012 - 03/2010
2Adenocarcinoma
02/2024 - 01/2018
2Cholangiocarcinoma
02/2023 - 01/2022
2Hepatocellular Carcinoma (Hepatoma)
02/2023 - 04/2019
2Adrenocortical Hyperfunction (Adrenal Gland Hyperfunction)
01/2022 - 01/2021
2Genomic Instability
10/2021 - 04/2019
2Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2017 - 12/2016
2Biliary Tract Neoplasms (Biliary Tract Cancer)
10/2017 - 01/2015
2Microsatellite Instability
05/2009 - 05/2002
1Sarcoma (Soft Tissue Sarcoma)
02/2024
1Renal Cell Carcinoma (Grawitz Tumor)
01/2023
1Residual Neoplasm
01/2022
1Transitional Cell Carcinoma
12/2021
1Dysuria
12/2021
1Thrombophilia
01/2021
1Thrombosis (Thrombus)
01/2021
1Chromosomal Instability (Chromosome Stability)
05/2019
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Mouth Neoplasms (Oral Cancer)
01/2018
1Carcinogenesis
01/2018
1Squamous Cell Carcinoma of Head and Neck
01/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2017
1Neutropenia
10/2017
1Vomiting
10/2017
1Nausea
10/2017
1Chromothripsis
09/2017
1Chromosome Aberrations (Chromosome Abnormalities)
09/2017
1Multiple Myeloma
09/2017
1Deafness (Deaf Mutism)
01/2017
1Blindness (Hysterical Blindness)
01/2017
1Obesity
01/2017

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
02/2024 - 05/2009
5Cell-Free Nucleic AcidsIBA
04/2019 - 05/2009
4DNA (Deoxyribonucleic Acid)IBA
02/2024 - 03/2007
4Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2016
4GemcitabineFDA Link
10/2017 - 08/2011
3Sorafenib (BAY 43-9006)FDA Link
12/2021 - 04/2019
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2017 - 03/2003
2trilostaneFDA Link
01/2022 - 01/2021
2Circulating Tumor DNAIBA
12/2021 - 10/2021
2RNA (Ribonucleic Acid)IBA
01/2021 - 05/2019
2MelatoninIBA
01/2019 - 01/2016
2CarcinogensIBA
01/2019 - 04/2008
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2017 - 12/2016
2Vincristine (Oncovin)FDA LinkGeneric
11/2017 - 12/2016
2Rituximab (Mabthera)FDA Link
11/2017 - 12/2016
2Prednisone (Sone)FDA LinkGeneric
11/2017 - 12/2016
2Cisplatin (Platino)FDA LinkGeneric
10/2017 - 08/2011
2NucleotidesIBA
09/2017 - 04/2016
2Histones (Histone)IBA
04/2016 - 09/2007
2ErbB Receptors (EGF Receptor)IBA
11/2011 - 03/2010
2Gefitinib (Iressa)FDA Link
08/2011 - 07/2011
2Codon (Codons)IBA
07/2011 - 02/2002
2AntigensIBA
03/2011 - 06/2008
1sotorasibIBA
02/2024
1Canertinib (CI 1033)IBA
01/2022
1toceranib phosphateIBA
01/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2021
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
12/2021
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2021
1Mitogen-Activated Protein KinasesIBA
08/2021
1VemurafenibIBA
08/2021
1Phosphotransferases (Kinase)IBA
08/2021
1fibrin fragment D (D-dimer)IBA
01/2021
1Clopidogrel (Plavix)FDA Link
01/2021
1Formaldehyde (Formol)FDA Link
11/2019
1Histone-Lysine N-MethyltransferaseIBA
11/2019
1ParaffinIBA
11/2019
1Apoptosis Regulatory ProteinsIBA
05/2019
1Phenobarbital (Luminal)FDA Link
05/2019
1Estrogen ReceptorsIBA
05/2019
1HLA-DRB1*04 antigenIBA
02/2019
1HLA-DQA1 antigen (HLA DQA1)IBA
02/2019
1HLA-DQB1 antigen (HLA DQB1)IBA
02/2019
1HLA Antigens (Human Leukocyte Antigens)IBA
02/2019
1HLA-DRB1 Chains (HLA DRB1)IBA
02/2019
1Etoposide (VP 16)FDA LinkGeneric
01/2019
1Small Interfering RNA (siRNA)IBA
01/2019
1DecitabineFDA Link
01/2018
1GalaninIBA
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017
1AlbuminsIBA
09/2017

Therapy/Procedure

8Therapeutics
02/2023 - 08/2011
4Drug Therapy (Chemotherapy)
01/2022 - 08/2011
2Adjuvant Chemotherapy
01/2023 - 01/2022
1Oral Administration
01/2022
1Subcutaneous Injections
01/2021
1Neoadjuvant Therapy
11/2019
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2017
1Induction Chemotherapy
10/2017
1Aftercare (After-Treatment)
09/2017
1Radiotherapy
01/2017